CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Have you seen this provider?
Locations and Appointments
Get Directionsto 161 Fort Washington Avenue (opens in new tab)
Insurances Accepted
Before your appointment, please contact the doctor's office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.
- Aetna Signature Administrators
- Medicare Managed Care
- HMO
- PPO
- POS
- EPO
- NY Signature
- Student Health
- Essential Plan
- Medicaid Managed Care
- Special Needs
- PPO
- HMO
- Great West (National)
- EPO
- POS
- Special Needs
- PPO
- Medicare Managed Care
- Select Care (Exchange)
- Vytra
- EPO
- Medicare Managed Care
- HMO
- PPO
- POS
- ConnectiCare
- Essential Plan
- Medicaid Managed Care
- Medicaid Managed Care
- Child/Family Health Plus
- Essential Plan
- PPO
- Medicare Managed Care
- HMO
- EPO
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Child/Family Health Plus
- Medicare Managed Care
- Medicare Managed Care
- Local 1199
- MagnaCare
- Traditional Medicare
- Multiplan
- HMO
- Essential Plan
- Child/Family Health Plus
- Medicaid Managed Care
- HMO
- POS
- PPO
- Empire Plan
- Oxford Liberty
- Oxford Freedom
- Oxford HMO
- Medicare Managed Care
- Medicaid (Community Plan)
- SelectHealth
- Medicare Managed Care
- Special Needs
- Medicaid Managed Care
- Medicare Managed Care
- World Trade Center Health Plan
About Ron Gejman, MD, PHD
Ron S. Gejman, MD, PhD is an Assistant Professor of Medicine in the Division of Hematology/Oncology at Columbia University Vagelos College of Physicians and Surgeons and a medical oncologist at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Gejman specializes in the treatment of advanced skin cancers, including melanoma and non-melanoma skin cancers such as squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. He specializes in the care of patients with skin cancers that arise in the setting of solid organ transplantation and other forms of immune suppression. Dr. Gejman's research is centered on cancer immunology and the development of new cellular therapies for patients with cancer. His research centers around how tumor microenvironment and immunosuppressive medications shape the immune response. In addition, he develops new immune-informed therapeutic strategies for the treatment of advanced skin cancers. Dr. Gejman received his BA from Columbia University and completed his MD and PhD through the Tri-Institutional MD-PhD Program at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University. His doctoral research focused on T cell recognition of tumor antigens. He completed residency training in Internal Medicine at Brigham and Women's Hospital/Harvard Medical School and fellowship training in Hematology/Oncology at Columbia University/NewYork-Presbyterian Hospital. Dr. Gejman's research has been supported by the National Cancer Institute, the Cancer Research Institute, and the American Society of Clinical Oncology among others. He is committed to integrating state-of-the-art clinical care with translational research aimed at developing safer and more effective immune-based therapies for patients with advanced skin cancers, including those whose treatment options are limited by organ transplantation or chronic immunosuppression.
Board Certifications
Languages Spoken
EDUCATION
- Medical School: Weill Cornell Medical College
- Residency: Brigham and Women’s Hospital
- Fellowship: New York Presbyterian Hospital
LEADERSHIP, TITLES & POSITIONS
- Assistant Professor of Medicine at the CUMC
HOSPITAL AFFILIATIONS
- NewYork-Presbyterian / Columbia University Irving Medical Center
